Opportunities for ovarian reserve preservation in the treatment of oncological diseases
This article presents the data of multi-year research on the problem of ovarian reserve preservation in cancer patients. The review includes 64 literary sources. The review provides the main methods for ovarian function preservation during the treatment of malignant diseases in patients of reproduct...
Main Authors: | Juliia E. Dobrokhotova, Kseniia V. Morozova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Berlin A.V.
2020-04-01
|
Series: | Гинекология |
Subjects: | |
Online Access: | https://gynecology.orscience.ru/2079-5831/article/viewFile/33949/21565 |
Similar Items
-
Gonadotropin-releasing hormone agonists during chemotherapy for ovarian function and fertility preservation for patients with early-stage breast cancer
by: Abdel-Razeq H
Published: (2019-05-01) -
Effect of gonadotropin-releasing hormone agonist on ES-2 ovarian cancer cells
by: Kuan-Hao Tsui, et al.
Published: (2014-03-01) -
ENDOMETRIOSIS AND FERTILITY. KEY MOMENT OF TREATMENT
by: S. A. Gasparyan, et al.
Published: (2016-06-01) -
Ovarian Cyst Formation Following Gonadotropin-Releasing Hormone-Agonist Administration Decreases the Oocyte Quality in IVF Cycles
by: Muammer Doğan, et al.
Published: (2012-06-01) -
Comparison of gonadotropin-releasing hormone agonist with GnRH antagonist in polycystic ovary syndrome patients undergoing in vitro fertilization cycle: Retrospective analysis from a tertiary center and review of literature
by: Neeta Singh, et al.
Published: (2014-01-01)